Overview

Biomedicines and Bacterial Translocation in Spondyloarthritis

Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to evaluate the effect of anti-TNF and anti-IL17 biotherapies on bacterial translocation in patients with NSAID-resistant axial spondyloarthritis.
Phase:
N/A
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Treatments:
Antibodies
Immunoglobulins